Building Resilience and Innovation: California’s Pharmaceutical Renaissance California is quietly staging a pharmaceutical renaissance, not of arts or culture this time, but of science, supply chains, and life-changing therapies. As the backbone of biopharma innovation in the U.S., the Golden State is becoming a place of industry transformation, embodied most recently by investments from Amgen and Gilead. A hub for pioneer science Amgen’s recent investment of $600 million to build a cutting-edge science ...